1. Home
  2. SFST vs TECX Comparison

SFST vs TECX Comparison

Compare SFST & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southern First Bancshares Inc.

SFST

Southern First Bancshares Inc.

HOLD

Current Price

$59.67

Market Cap

421.9M

Sector

Finance

ML Signal

HOLD

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$21.26

Market Cap

393.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFST
TECX
Founded
1999
2019
Country
United States
United States
Employees
N/A
51
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
421.9M
393.0M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
SFST
TECX
Price
$59.67
$21.26
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$64.00
$80.40
AVG Volume (30 Days)
30.1K
529.5K
Earning Date
04-23-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
15.06
N/A
EPS
2.54
N/A
Revenue
$5,560,000.00
N/A
Revenue This Year
$10.47
N/A
Revenue Next Year
$12.19
N/A
P/E Ratio
$23.91
N/A
Revenue Growth
37.76
N/A
52 Week Low
$29.80
$13.70
52 Week High
$61.06
$27.64

Technical Indicators

Market Signals
Indicator
SFST
TECX
Relative Strength Index (RSI) 58.21 49.15
Support Level $50.27 $16.88
Resistance Level $61.06 $25.39
Average True Range (ATR) 1.72 2.35
MACD 0.01 -0.22
Stochastic Oscillator 64.53 47.66

Price Performance

Historical Comparison
SFST
TECX

About SFST Southern First Bancshares Inc.

Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: